These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25072031)

  • 1. Evaluation of eight live attenuated vaccine candidates for protection against challenge with virulent Mycobacterium avium subspecies paratuberculosis in mice.
    Bannantine JP; Everman JL; Rose SJ; Babrak L; Katani R; Barletta RG; Talaat AM; Gröhn YT; Chang YF; Kapur V; Bermudez LE
    Front Cell Infect Microbiol; 2014; 4():88. PubMed ID: 25072031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and protective efficacy of the Mycobacterium avium subsp. paratuberculosis attenuated mutants against challenge in a mouse model.
    Chen JW; Faisal SM; Chandra S; McDonough SP; Moreira MA; Scaria J; Chang CF; Bannantine JP; Akey B; Chang YF
    Vaccine; 2012 Apr; 30(19):3015-25. PubMed ID: 22107851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rational framework for evaluating the next generation of vaccines against Mycobacterium avium subspecies paratuberculosis.
    Bannantine JP; Hines ME; Bermudez LE; Talaat AM; Sreevatsan S; Stabel JR; Chang YF; Coussens PM; Barletta RG; Davis WC; Collins DM; Gröhn YT; Kapur V
    Front Cell Infect Microbiol; 2014; 4():126. PubMed ID: 25250245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of two mutants of Mycobacterium avium subsp. paratuberculosis as candidates for a live attenuated vaccine for Johne's disease.
    Park KT; Allen AJ; Bannantine JP; Seo KS; Hamilton MJ; Abdellrazeq GS; Rihan HM; Grimm A; Davis WC
    Vaccine; 2011 Jun; 29(29-30):4709-19. PubMed ID: 21565243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior Protection from Live-Attenuated Vaccines Directed against Johne's Disease.
    Shippy DC; Lemke JJ; Berry A; Nelson K; Hines ME; Talaat AM
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27806993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of novel oral vaccine candidates and validation of a caprine model of Johne's disease.
    Hines ME; Turnquist SE; Ilha MR; Rajeev S; Jones AL; Whittington L; Bannantine JP; Barletta RG; Gröhn YT; Katani R; Talaat AM; Li L; Kapur V
    Front Cell Infect Microbiol; 2014; 4():26. PubMed ID: 24624365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior protection elicited by live-attenuated vaccines in the murine model of paratuberculosis.
    Ghosh P; Shippy DC; Talaat AM
    Vaccine; 2015 Dec; 33(51):7262-7270. PubMed ID: 26546738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated strains of Mycobacterium avium subspecies paratuberculosis as vaccine candidates against Johne's disease.
    Settles EW; Kink JA; Talaat A
    Vaccine; 2014 Apr; 32(18):2062-9. PubMed ID: 24565753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Mycobacterium avium subsp. paratuberculosis leuD mutant as a vaccine candidate against challenge in a caprine model.
    Faisal SM; Chen JW; Yan F; Chen TT; Useh NM; Yan W; Guo S; Wang SJ; Glaser AL; McDonough SP; Singh B; Davis WC; Akey BL; Chang YF
    Clin Vaccine Immunol; 2013 Apr; 20(4):572-81. PubMed ID: 23408524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of Mycobacterium avium subsp. paratuberculosis mutants for attenuation in a bovine monocyte-derived macrophage model.
    Lamont EA; Talaat AM; Coussens PM; Bannantine JP; Grohn YT; Katani R; Li LL; Kapur V; Sreevatsan S
    Front Cell Infect Microbiol; 2014; 4():87. PubMed ID: 25072030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium avium subsp. paratuberculosis antibody response, fecal shedding, and antibody cross-reactivity to Mycobacterium bovis in M. avium subsp. paratuberculosis-infected cattle herds vaccinated against Johne's disease.
    Tewari D; Hovingh E; Linscott R; Martel E; Lawrence J; Wolfgang D; Griswold D
    Clin Vaccine Immunol; 2014 May; 21(5):698-703. PubMed ID: 24623626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of live candidate vaccines for paratuberculosis in animal models and macrophages.
    Scandurra GM; de Lisle GW; Cavaignac SM; Young M; Kawakami RP; Collins DM
    Infect Immun; 2010 Mar; 78(3):1383-9. PubMed ID: 20038535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of
    Eshraghisamani R; Arrazuria R; Luo L; De Buck J
    Front Cell Infect Microbiol; 2023; 13():1149419. PubMed ID: 37065210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection efficacy of Argentinian isolates of Mycobacterium avium subsp. paratuberculosis with different genotypes and virulence in a murine model.
    Colombatti Olivieri MA; Moyano RD; Traveria GE; Alvarado Pinedo MF; Mon ML; Gravisaco MJ; Delgado FO; Santangelo MP; Romano MI
    Res Vet Sci; 2018 Dec; 121():4-11. PubMed ID: 30300853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Salmonella vectored vaccine expressing Mycobacterium avium subsp. paratuberculosis antigens against challenge in a goat model.
    Faisal SM; Yan F; Chen TT; Useh NM; Guo S; Yan W; Wang SJ; Glaser AL; McDonough SP; Singh B; Chang YF
    PLoS One; 2013; 8(8):e70171. PubMed ID: 23950909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a Ferret Model to Test Efficacy and Immunogenicity of Live Attenuated Mycobacterium avium Subspecies paratuberculosis Vaccines.
    Bannantine JP; Gupta T; Zinniel DK; Hikal A; Quinn FD; Barletta RG
    Methods Mol Biol; 2022; 2411():95-104. PubMed ID: 34816400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bovine macrophage screening system for identifying attenuated transposon mutants of Mycobacterium avium subsp. paratuberculosis with vaccine potential.
    Scandurra GM; Young M; de Lisle GW; Collins DM
    J Microbiol Methods; 2009 Apr; 77(1):58-62. PubMed ID: 19386227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of novel lipid-formulated whole bacterial cell vaccines against Mycobacterium avium subsp. paratuberculosis in sheep.
    Griffin JF; Hughes AD; Liggett S; Farquhar PA; Mackintosh CG; Bakker D
    Vaccine; 2009 Feb; 27(6):911-8. PubMed ID: 19059295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of 'indigenous vaccine' using native 'Indian bison type' genotype of Mycobacterium avium subspecies paratuberculosis for the control of clinical Johne's disease in an organized goat herd.
    Singh K; Chandel BS; Chauhan HC; Dadawala A; Singh SV; Singh PK
    Vet Res Commun; 2013 Jun; 37(2):109-14. PubMed ID: 23345101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of spheroplastic and cell-wall competent vaccines for Mycobacterium avium subsp. paratuberculosis in experimentally-challenged baby goats.
    Hines ME; Stiver S; Giri D; Whittington L; Watson C; Johnson J; Musgrove J; Pence M; Hurley D; Baldwin C; Gardner IA; Aly S
    Vet Microbiol; 2007 Mar; 120(3-4):261-83. PubMed ID: 17123751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.